Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Explore the inspiring stories of the Fierce 50
Maze Therapeutics
Biotech
Sanofi to enter Maze deal with $750M pact for Pompe med
Sanofi is betting up to $750 million to license a phase 2-ready treatment for Pompe disease from Maze Therapeutics.
Max Bayer
May 1, 2023 6:00am
BIO CEO out the door—Chutes & Ladders
Oct 14, 2022 9:30am
Discovery of ALS and dementia mechanism points to new treatment
Feb 23, 2022 11:00am
Maze snares $190M as its top asset aims for clinic
Jan 10, 2022 7:30am
What does a virtual J.P. Morgan mean for the meeting's future?
Jan 12, 2021 11:00am
Maze allies with BridgeBio and Alloy to create 2 biotechs
Dec 7, 2020 8:30am
